R&D capitalization changes are reshaping trial funding. The real impact hits clinical supply, where tax strategy now directly influences timelines, inventory, and execution.
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
- Designing Clinical Trials For Hard-To-Access Patients
- How Clinical Supply Teams Can Prevent Cross-Border Shipping Delays
- AI In Clinical Supply – Hype, Hope, And The Path To Predictive Precision
ON-DEMAND WEBINARS
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
This webinar brings together a panel of supply chain experts to bring insight into managing the uncertainty and risk that comes along with clinical supply decisions.
Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.
Guido D’Agostino, Head of Global Procurement at Chiesi, and Stefan Dürr, Senior Director of Product Management and Client Delivery at IQVIA IRT, delve into their achievements in sustainability.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![IRT Getty 1407865352]( "3 Study Areas Where Your IRT Vendor Should Do More")
3 Study Areas Where Your IRT Vendor Should Do MoreFind out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
![clinical-trial-supply-challenges-GettyImages-2161372208]( "Managing Clinical Trial Supply Challenges In Complex Studies")
Managing Clinical Trial Supply Challenges In Complex StudiesComplex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
![GettyImages-1163506017 labeling]( "IMP Labeling: EU CTR Transition Considerations")
IMP Labeling: EU CTR Transition ConsiderationsReview current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
![GettyImages-1368429013-vial]( "Overcoming Challenges In Cell And Gene Therapy Containment")
Overcoming Challenges In Cell And Gene Therapy ContainmentReview the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
![GettyImages-893884852 doctors tablet data]( "Study, Not Software: Aligning RTSM To The Protocol")
Study, Not Software: Aligning RTSM To The ProtocolHow can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![GettyImages-1305685152 vaccine]( "eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks")
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 WeeksExamine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
![GettyImages-155372946-cold-chain-cryopreservation-logistics]( "Ensuring On-Time Release Of CAR-T Cell Treatment In Spain")
Ensuring On-Time Release Of CAR-T Cell Treatment In SpainDue to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
![DD 2 - 2mL_10mL_Vials_Tubs_Capped]( "Safeguarding Cell Therapy Cryopreservation: Primary Containers")
Safeguarding Cell Therapy Cryopreservation: Primary ContainersReview different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
